ELI LILLY & Co — Director's Dealing 2020

Feb 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-02-11

Reporting Person: Jonsson Patrik (SVP and Pres., Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-11	Common Stock	A	5702	$144.25	Acquired	25079	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	130	Indirect